Jun 3, 2026 08:03AM
Jun 3, 2026 08:00AM
May 19, 2026 05:33AM
May 18, 2026 08:01AM
May 18, 2026 08:00AM
May 7, 2026 04:15PM
Mar 16, 2026 07:05AM CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update
Mar 16, 2026 07:01AM
Mar 16, 2026 07:00AM
Jan 27, 2026 07:00AM
Jan 27, 2026 07:00AM
Jan 8, 2026 08:00AM
Dec 21, 2025 04:00AM
Aug 13, 2025 08:00AM CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study
Mar 11, 2024 04:10PM
Jan 24, 2024 08:01AM
Jan 24, 2024 08:00AM
Nov 17, 2022 07:01AM
Nov 17, 2022 07:00AM
Nov 17, 2022 07:00AM
Sep 7, 2022 06:05PM CytomX Therapeutics Presents Overview of Conditionally-Activated Antibody-Drug Conjugate (ADC) Programs Including Next Generation EpCAM-Targeting CX-2051
Jul 7, 2022 09:26AM
Jul 6, 2022 04:06PM
Jul 6, 2022 04:05PM
May 5, 2022 04:15PM
Mar 1, 2022 04:15PM
Jan 19, 2022 08:01AM
Jan 19, 2022 08:00AM CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-904 for the Treatment of Advanced Solid Tumors
Nov 4, 2021 04:15PM
Aug 5, 2021 04:15PM
Jan 20, 2021 09:20AM
Jan 19, 2021 05:44PM
Dec 29, 2020 07:42AM
Mar 24, 2020 09:14AM
Nov 20, 2019 09:16AM Pre-Open 11/20: (ARAV) (I) (TGT) Higher (PDD) (URBN) (MUX) Lower (more...)
Nov 19, 2019 05:57PM
Feb 27, 2019 04:08PM
Nov 6, 2018 04:05PM
Aug 8, 2018 04:04PM
May 22, 2018 07:32AM
May 22, 2018 07:30AM
Nov 28, 2017 08:34AM CytomX Therapeutics (CTMX) Announces FDA Acceptance of IND for CTLA-4 Probody Therapeutic
Nov 28, 2017 08:30AM
Oct 4, 2017 09:30AM
Oct 3, 2017 04:05PM
Sep 21, 2017 08:00AM
Mar 20, 2017 09:29AM

322,094 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All